Instead, we attempted to investigate the question under the hypothesis that, if alpha-1 blockers were indeed protective against severe COVID-19 symptoms, we should see a negative association between the prevalent use of alpha-1 blockers and COVID-19 related outcomes such as hospitalization. This evidence concerns the gene PSMA6 and COVID-19.